A review on analytical aspects of ethosuximide: An antiepileptic drug

One out of 50 individuals can have multiple epileptic convulsions during their life, necessitating the use
of antiepileptic medication for treatment. One of the most common illnesses of the brain is epilepsy.
Ethosuximide, also known as 2-ethyl-2-methylsuccinimide, is a commonly employed succinimide for the
management of seizures known as "petit mal seizures." It is also a useful substance for research on absence
seizures. When it comes to treating kids suffering from petit mal (generalized absence) epileptic seizures,
this medication is the best option, whether used alone or in combination. Ethosuximide's main mode of
action towards absence seizures is its inhibition of low-threshold T-type (Transient-type) calcium electrical
currents within thalamic nerve cells. At the beginning of ethosuximide therapy, nausea, abdominal pain,
vomiting, diarrhea, and anorexia are frequently experienced side effects. This article provides a complete
review of the "antiepileptic drug ethosuximide” which will be helpful for the researchers for their research
purposes.